North America Drug Delivery Systems Market 2027 By Route of Administration, Distribution Channel, and Application, and Country

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Drug Delivery Systems Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Drug Delivery Systems Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Growing demand for targeted drug delivery systems
5.1.2 Advancements in drug delivery technologies for chronic diseases

5.2 Market Opportunities

5.2.1 Advancements in drug delivery technologies creating opportunities for targeted and efficient drug delivery systems
5.2.2 Rising demand for personalized drug delivery driving market growth

5.3 Future Trends

5.3.1 Demand for non-invasive drug delivery systems
5.3.2 Advancements in controlled-release and personalized drug delivery solutions

5.4 Impact of Drivers and Restraints

6. North America Drug Delivery Systems Market Regional Analysis

6.1 North America Drug Delivery Systems Market Overview

6.2 North America Drug Delivery Systems Market Revenue 2016-2027 (US$ Million)

6.3 North America Drug Delivery Systems Market Forecast Analysis

7. North America Drug Delivery Systems Market Analysis – by Route of Administration

7.1 Transmucosal

7.1.1 Overview
7.1.2 Transmucosal: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Oral

7.2.1 Overview
7.2.2 Oral: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Injectable

7.3.1 Overview
7.3.2 Injectable: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Topical

7.4.1 Overview
7.4.2 Topical: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Implantable

7.5.1 Overview
7.5.2 Implantable: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Ocular

7.6.1 Overview
7.6.2 Ocular: North America Drug Delivery Systems Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Drug Delivery Systems Market Analysis – by Distribution Channel

8.1 Hospital Pharmacies

8.1.1 Overview
8.1.2 Hospital Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Retail Pharmacies

8.2.1 Overview
8.2.2 Retail Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Online Pharmacies

8.3.1 Overview
8.3.2 Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Drug Delivery Systems Market Analysis – by Application

9.1 Home Care Settings

9.1.1 Overview
9.1.2 Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Hospitals & Clinics

9.2.1 Overview
9.2.2 Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Drug Delivery Systems Market – North America Analysis

10.1 North America

10.1.1 North America Drug Delivery Systems Market Breakdown, by Key Country, 2019 and 2027 (%)
10.1.1.1 North America Drug Delivery Systems Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 US: North America Drug Delivery Systems Market Breakdown, by Route of Administration
10.1.1.1.2 US: North America Drug Delivery Systems Market Breakdown, by Distribution Channel
10.1.1.1.3 US: North America Drug Delivery Systems Market Breakdown, by Application

10.1.1.2 Canada: North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Canada: North America Drug Delivery Systems Market Breakdown, by Route of Administration
10.1.1.2.2 Canada: North America Drug Delivery Systems Market Breakdown, by Distribution Channel
10.1.1.2.3 Canada: North America Drug Delivery Systems Market Breakdown, by Application

10.1.1.3 Mexico : North America Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Mexico : North America Drug Delivery Systems Market Breakdown, by Route of Administration
10.1.1.3.2 Mexico : North America Drug Delivery Systems Market Breakdown, by Distribution Channel
10.1.1.3.3 Mexico : North America Drug Delivery Systems Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Drug Delivery Systems Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BD

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Novo Nordisk A/S

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 3M

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Boston Scientific Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Bausch Health Companies Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Baxter International, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Boehringer Ingelheim

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Novartis AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 GlaxoSmithKline plc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Johnson & Johnson Services, Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights